NASH Clinical Trials: Challenges and Considerations

Dr. Andrew Roche discusses overcoming the challenges and considerations associated with NASH Clinical Trials and examination of potential strategies to address during trial design or study execution.

46:50

The Template for a Successful Digital Trial

Industry Leaders Marie Mc Carthy (ICON PLC) and Chen Admati (Intel) explore a few best practices for implementing a successful digital trial

1:00:43

Effective Ingestion and Normalisation of Real World Data Sources

50:02

How Real World Evidence Continues to Shape the Late Phase Research Landscape

This webinar explores Real World Evidence Dynamics and Alignment with Late Phase Research, Developing an RWE Strategy and Connecting Technology to an RWE Strategy. Presented by Bill Row, Holly Watts, Bruce Capobianco

58:08

Industry Analysis_ Impact of FDA’s Recent Guidance on Payer Communications

Our experts explore how manufacturers can successfully implement the FDA's guidance on Payer Communications and integrate these new communication channels with payers

57:23

Industry Perceptions and Expectations_ The Role of ICER as an Independent HTA

This webinar explores: the evolution of health technology assessment in the US and possibilities for the future; opinions of manufacturers and US payer stakeholders on the role of ICER in the US healthcare system; ICER methodologies and approaches

1:02:20